Atlas Trials

Expanded Access to Tipifarnib

Clinical trial NCT04809233 · AVAILABLE

Trial details

NCT number
NCT04809233
Sponsor
Kura Oncology, Inc.
Status
AVAILABLE
Study type
EXPANDED_ACCESS
HRAS Mutations or Peripheral T Cell Lymphoma (PTCL)

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.